Chikungunya virus-associated encephalitis

Neurology

Volumn 86, Issue 1, 2016, Pages 94-102

  Gérardin, Patrick ^a,b   Couderc, Thérèse ^c,d   Bintner, Marc ^a   Tournebize, Patrice ^a   Renouil, Michel ^a   Lémant, JéRome ^a   Boisson, Véronique ^a   Borgherini, Gianandrea ^a   Staikowsky, Frédérik ^e   Schramm, Frédéric ^f   Lecuit, Marc ^c,d,g,h   Michault, Alain ^a,b  

^a Centre Hospitalier Universitaire (CHU)   (France)

^b UNIVERSITÉ DE LA RÉUNION   (France)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN EDEMA; CEREBELLUM HEMORRHAGE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CHIKUNGUNYA VIRUS ASSOCIATION ENCEPHALITIS; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; DEHYDRATION; DEMENTIA; DISABILITY; DISEASE SEVERITY; ENCEPHALITIS; FATALITY; FEMALE; HUMAN; HYPERNATREMIA; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; METABOLIC ENCEPHALOPATHY; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; NEWBORN PERIOD; OUTCOME ASSESSMENT; PNEUMOCOCCAL MENINGITIS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; CHIKUNGUNYA FEVER; FOLLOW UP; MIDDLE AGED; NEWBORN; PROSPECTIVE STUDY; REUNION;

ADULT; AGED; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; COHORT STUDIES; ENCEPHALITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; REUNION;

EID: 84952342917     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002234     Document Type: Article

References (40)

1. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of re-emerging infectious disease. Clin Infect Dis 2009; 49: 942-948
2. Weaver SC, Winegar R, Manger ID, Forrester NL. Alphaviruses: population genetics and determinants of emergence. Antivir Res 2012; 94: 242-257
3. Brighton SW, Prozesky OW, De La Harpe AL. Chikungunya virus infection: a retrospective study of 107 cases. S Afr Med J 1983; 63: 313-315
4. Chastel C. Human infections in Cambodia by the Chikungunya virus or a closely related agent: serology. Bull Soc Path Exot 1963; 56: 892-915
5. Carey DE, Myers RM, DeRanitz CM, Jadhav M, Reuben R. The 1964 Chikungunya epidemic at Vellore, South India, including observations on concurrent dengue. Trans R Soc Trop Med Hyg 1969; 63: 434-445
6. Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006; 3: e263
7. Tsetsarkin KA, Vanlandingham DL, Mc Gee CE, Higgs S. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3: e201
8. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, De Lamballerie X. Chikungunya in the Americas. Lancet 2014; 383: 514
9. Miner JJ, Aw-Yeang YH, Fox JM, et al. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol 2015; 67: 1214-1220
10. Teo TH, Her Z, Tan JJ, et al. Carribbean and La Réunion Chikungunya virus isolates differ in the capacity to induce pro-inflammatory Th1 and NK cell responses and acute joint pathology. J Virol 2015; 89: 7955-7969
11. Gérardin P, Guernier V, Perrau J, et al. Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis 2008; 8: 99
12. Lemant J, Boisson V, Winer A, et al. Serious acute Chikungunya virus infection requiring intensive care during the Réunion Island outbreak in 2005-2006. Crit Care Med 2008; 36: 2536-2541
13. Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Réunion. PLoS Med 2008; 5: e60
14. Tournebize P, Charlin C, Lagrange M. Neurological manifestations in Chikungunya: about 23 cases collected in Réunion Island [in French]. Rev Neurol 2009; 165: 48-51
15. Ganesan K, Diwan A, Shankar SK, et al. Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1case with autopsy findings. AJNR Am J Neuroradiol 2008; 29: 1636-1637
16. Lebrun G, Khadda K, Reboux AH, Martinet O, Gaüzère BA. Guillain-Barré syndrome after Chikungunya infection. Emerg Infect Dis 2009; 15: 495-496
17. Gérardin P, Fianu A, Malvy D, et al. Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based-cohort study. BMC Med 2011; 9: 5
18. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis 2013; 57: 1114-1128
19. Mailles A, Stahl JP. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009; 49: 1838-1847
20. Beers SR, Wisniewski SR, Garcia-Fillion P, et al. Validity of a pediatric version of the Glasgow Outcome Scale-Extended. J Neurotrauma 2012; 29: 1126-1139
21. Vora NM, Holman RC, Mehal JM, Steiner CA, Blanton J, Sejvar J. Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology 2014; 82: 443-451
22. Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults: Association of British Neurologists and British Infection Association National guidelines. J Infect 2012; 64: 347-363
23. Mailles A, Vaillant V, Stahl JP. Encéphalites infectieuses: données et limites du PMSI pour létude épidémiologique, France métropolitaine 2000-2002. Med Mal Infect 2007; 37: 95-102
24. Reimann CA, Hayes EB, DiGuiseppi C, et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. Am J Trop Med Hyg 2008; 76: 974-979
25. Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011; 89: 766-774
26. Rampal, Sharda M, Meena H. Neurological complications in Chikungunya fever. J Assoc Physicians India 2007; 55: 765-769
27. Lewthwaite P, Vasanthapuram R, Osborne JC, et al. Chikungunya virus and central nervous system infections in children, India. Emerg Infect Dis 2009; 15: 329-331
28. Chusri S, Siripaitoon P, Hirunpat S, Silpapojakul K. Short report: cases reports of neurochikungunya in southern Thailand. Am J Trop Med Hyg 2011; 85: 386-389
29. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43: 1565-1577
30. Granerod J, Ambrose HE, Davies NWS, Clewley JP, Walsh AL, Morgan D. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10: 835-844
31. Mailles A, De Broucker T, Costanzo P, et al. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis 2012; 54: 1455-1464
32. Steiner I, Kennedy PGE, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007; 6: 1015-1028
33. Sejvar J. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007; 44: 1617-1624
34. Gaensbauer JT, Lindsey NP, Messacar K, Staples JE, Fischer M. Neuroinvasive arboviral disease in the United States: 2003 to 2012. Pediatrics 2014; 134: e642-e650
35. Couderc T, Chrétien F, Schilte C, et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008; 4: e29
36. Labadie K, Larcher T, Joubert C, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 3: 894-906
37. Fraisier C, Koraka P, Belghazi M, et al. Kinetic analysis of mouse brain proteome alterations following Chikungunya virus infection before and after appearance of clinical symptoms. PLoS One 2014; 9: e91397
38. Adkins B, Marshall-Clarke S, Leclerc C. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4: 553-564
39. Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol 2010; 140: 281-286
40. Gérardin P, Sampériz S, Ramful D, et al. Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Réunion Island. PLoS Negl Trop Dis 2014; 8: e2996